Call Us @ 0172 - 4680800 | info@indswift.com | NETWORKS | NSE - BSE

Investors

Unaudited Financial Results for the Quarter ended 30th September, 2008
(RS. IN LACS)
PARTICULARS Unaudited Qtr. ended 30.09.08 Unaudited Qtr. ended 30.09.07 Unaudited half Year ended 30.09.08 Unaudited half Year ended year 30.09.07 Audited year ended 31.03.08
INCOME FROM OPERATIONS
14608.43
12244.97
27446.28
23314.50
51560.36
OTHER INCOME
41.05
28.72
58.42
45.17
361.08
TOTAL INCOME
14649.48
12273.69
27504.70
23359.67
51921.44
EXPENDITURE
DECREASE IN STOCK IN TRADE
-301.10
-1452.45
-1248.39
237.84
-4705.44
CONSUMPTION OF RAW MATERIAL
6441.20
6428.69
11199.15
8607.01
22277.91
COST OF SALES
4443.71
4024.28
9943.47
8263.98
22277.91
STAFF COST
478.63
411.36
918.75
789.03
1659.93
OTHER EXPENSES
260.00
110.00
440.00
220.00
585.60
TOTAL EXPENDITURE
12701.95
10791.25
23873.31
20539.56
45117.05
INTEREST
826.83
619.56
1624.52
1177.49
2954.56
PROFIT BEFORE TAX
1120.70
862.88
2006.87
1642.62
3849.83
PROVISION FOR TAX(INCL.FBT)
141.97
107.76
257.37
206.10
433.94
PROVISION FOR DEFFERED TAX
100.00
100.00
250.00
250.00
291.34
NET PROFIT
878.73
655.12
1499.50
1186.52
3124.55
SHARE CAPITAL
743.57
743.57
743.57
743.57
743.57
PUBLIC SHARE HOLDING
No. OF SHARES
23578735
23931582
23578735
23931582
23633517
% AGE OF TOTAL HOLDING
63.42
64.37
63.42
64.37
63.57
 
Notes:-

1. During the quarter under review, the Income of the company has grown 19.36% and Profit Before Tax has shown an increase of 29.88% as compared to the same period in the previous year.

2.The company is exclusively in the pharamaceutical business segment only.

3.Information on investor's Complaints for the quarter: Opening: nil, Received: 2, Pending:Nil

4.Previous period figures have been re-grouped/ or rearranged wherever necessary.

5. The above results were taken on record by the Audit Committee and Board of Directors at their respective meetings held on 29th October 2007

By the order of the Board
 
Dated : 25.10.2008  
(S.R. Mehta)
Place: Chandigarh  
Chairman